Patent ID: 8541440

Claim:
A method of treating a disorder associated with dysfunction of the nicotinic receptors, comprising administering to a patient in need of said treatment a therapeutically effective amount of a compound of formula (I): in which: R represents a group chosen from pyrazolyl, imidazolyl, triazolyl, oxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, thiadiazolyl and tetrazolyl, said group optionally substituted with one or more groups chosen from halogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, trifluoromethoxy, trifluoromethyl, nitro, cyano, hydroxyl, amino, (C 1 -C 6 )alkylamino and di(C 1 -C 6 )alkylamino group; and wherein the carbon-carbon bond between positions 3 and 4 of the azabicyclooctane ring is a single or a double bond; or a pharmaceutically acceptable salt thereof; wherein the disorder is selected from the group consisting of executive function disorders associated with Alzheimer's disease and schizophrenia.